Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma, Kaposi 1HIV Infections 1Glioma 1AIDS-related Kaposi sarcoma 1

Interventions

Cyclophosphamide 548pembrolizumab 386Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 316Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 273Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 173Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Has results × efineptakin alfa × Clear all
NCT03687957 2025-11-25

rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide

Washington University School of Medicine

Phase 1/2 Active not recruiting
42 enrolled 19 charts
CNS

Glioma

NCT04893018 2024-06-27

NT-I7 for Kaposi Sarcoma in Patients With or Without HIV

Fred Hutchinson Cancer Center

Phase 1 Terminated
8 enrolled 14 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡